- Home
- STHO vs COYA Comparison
STHO vs COYA Comparison
Compare STHO & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- COYA
- Stock Information
- Founded
- STHO N/A
- COYA 2020
- Country
- STHO United States
- COYA United States
- Employees
- STHO N/A
- COYA N/A
- Industry
- STHO Real Estate
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- STHO Real Estate
- COYA Health Care
- Exchange
- STHO Nasdaq
- COYA Nasdaq
- Market Cap
- STHO 89.7M
- COYA 107.0M
- IPO Year
- STHO N/A
- COYA 2022
- Fundamental
- Price
- STHO $8.13
- COYA $6.15
- Analyst Decision
- STHO
- COYA Strong Buy
- Analyst Count
- STHO 0
- COYA 4
- Target Price
- STHO N/A
- COYA $16.50
- AVG Volume (30 Days)
- STHO 44.3K
- COYA 59.2K
- Earning Date
- STHO 08-07-2025
- COYA 08-12-2025
- Dividend Yield
- STHO N/A
- COYA N/A
- EPS Growth
- STHO N/A
- COYA N/A
- EPS
- STHO N/A
- COYA N/A
- Revenue
- STHO $113,989,000.00
- COYA $423,452.00
- Revenue This Year
- STHO N/A
- COYA $40.52
- Revenue Next Year
- STHO N/A
- COYA N/A
- P/E Ratio
- STHO N/A
- COYA N/A
- Revenue Growth
- STHO N/A
- COYA N/A
- 52 Week Low
- STHO $6.06
- COYA $4.65
- 52 Week High
- STHO $14.50
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- STHO 65.18
- COYA 51.12
- Support Level
- STHO $7.05
- COYA $5.60
- Resistance Level
- STHO $7.45
- COYA $6.28
- Average True Range (ATR)
- STHO 0.29
- COYA 0.41
- MACD
- STHO 0.09
- COYA -0.04
- Stochastic Oscillator
- STHO 88.89
- COYA 49.11
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.